Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	HSPG2 PCDHGA9 FSTL5 CDHR5 TENM2 EDEM3 FAT1 PPP2R3A CELSR1 FAT2 CELSR2 BRAF LRP4 LTBP2 PCDHGA8	6.99e-05	749	125	15	GO:0005509
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	PCDHGA9 TRO CDHR5 KIRREL3 FAT1 CELSR1 FAT2 CELSR2 PKD1 PCDHGA8	2.12e-07	187	125	10	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	PCDHGA9 TRO CDHR5 WNK1 TENM2 KIRREL3 FAT1 CELSR1 FAT2 CELSR2 PKD1 PCDHGA8	4.61e-07	313	125	12	GO:0098742
GeneOntologyCellularComponent	chromatin lock complex	RB1 L3MBTL1	1.06e-04	3	125	2	GO:0061793
MousePheno	abnormal pericardial cavity morphology	HSPG2 FLT4 RB1 BICRA WNK1 BRAF PKD1	4.95e-05	128	105	7	MP:0012501
MousePheno	abnormal cardinal vein morphology	HSPG2 FLT4 WNK1 BRAF	5.36e-05	28	105	4	MP:0004783
MousePheno	heart hemorrhage	HSPG2 FLT4 WNK1 BRAF PKD1	5.61e-05	55	105	5	MP:0009698
Domain	LamG	HSPG2 COL18A1 FAT1 CELSR1 FAT2 CELSR2 CSPG4	1.42e-08	44	123	7	SM00282
Domain	Laminin_G	HSPG2 COL18A1 FAT1 CELSR1 FAT2 CELSR2 CSPG4	1.03e-07	58	123	7	IPR001791
Domain	LAM_G_DOMAIN	HSPG2 FAT1 CELSR1 FAT2 CELSR2 CSPG4	1.68e-07	38	123	6	PS50025
Domain	Laminin_G_2	HSPG2 FAT1 CELSR1 FAT2 CELSR2 CSPG4	2.31e-07	40	123	6	PF02210
Domain	Cadherin	PCDHGA9 CDHR5 FREM1 FAT1 CELSR1 FAT2 CELSR2 PCDHGA8	1.12e-06	118	123	8	IPR002126
Domain	EGF_CA	HSPG2 TENM2 FAT1 CELSR1 FAT2 CELSR2 LRP4 LTBP2	1.45e-06	122	123	8	SM00179
Domain	EGF-like_Ca-bd_dom	HSPG2 TENM2 FAT1 CELSR1 FAT2 CELSR2 LRP4 LTBP2	1.64e-06	124	123	8	IPR001881
Domain	Cadherin_CS	PCDHGA9 CDHR5 FAT1 CELSR1 FAT2 CELSR2 PCDHGA8	7.73e-06	109	123	7	IPR020894
Domain	CADHERIN_1	PCDHGA9 CDHR5 FAT1 CELSR1 FAT2 CELSR2 PCDHGA8	9.81e-06	113	123	7	PS00232
Domain	CADHERIN_2	PCDHGA9 CDHR5 FAT1 CELSR1 FAT2 CELSR2 PCDHGA8	1.04e-05	114	123	7	PS50268
Domain	-	PCDHGA9 CDHR5 FAT1 CELSR1 FAT2 CELSR2 PCDHGA8	1.04e-05	114	123	7	2.60.40.60
Domain	CA	PCDHGA9 CDHR5 FAT1 CELSR1 FAT2 CELSR2 PCDHGA8	1.10e-05	115	123	7	SM00112
Domain	Cadherin-like	PCDHGA9 CDHR5 FAT1 CELSR1 FAT2 CELSR2 PCDHGA8	1.17e-05	116	123	7	IPR015919
Domain	EGF	HSPG2 FAT1 CELSR1 FAT2 CELSR2 LRP4 LTBP2	2.00e-05	126	123	7	PF00008
Domain	-	HSPG2 FAT1 CELSR1 FAT2 CELSR2 CSPG4	3.89e-05	95	123	6	2.60.120.200
Domain	ARHGEF5_35	ARHGEF5 ARHGEF35	4.30e-05	2	123	2	PF15441
Domain	ARHGEF5/35_N	ARHGEF5 ARHGEF35	4.30e-05	2	123	2	IPR029212
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A5	5.87e-05	12	123	3	PF15371
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A5	5.87e-05	12	123	3	IPR027970
Domain	GPS	ADGRG1 CELSR1 CELSR2 PKD1	7.13e-05	34	123	4	SM00303
Domain	GPS	ADGRG1 CELSR1 CELSR2 PKD1	8.01e-05	35	123	4	PF01825
Domain	GPS	ADGRG1 CELSR1 CELSR2 PKD1	8.96e-05	36	123	4	PS50221
Domain	GPS	ADGRG1 CELSR1 CELSR2 PKD1	1.00e-04	37	123	4	IPR000203
Domain	Cadherin	PCDHGA9 FAT1 CELSR1 FAT2 CELSR2 PCDHGA8	1.03e-04	113	123	6	PF00028
Domain	EGF	HSPG2 TENM2 FAT1 CELSR1 FAT2 CELSR2 LRP4 LTBP2	1.66e-04	235	123	8	SM00181
Domain	EGF_3	HSPG2 TENM2 FAT1 CELSR1 FAT2 CELSR2 LRP4 LTBP2	1.66e-04	235	123	8	PS50026
Domain	EGF-like_dom	HSPG2 TENM2 FAT1 CELSR1 FAT2 CELSR2 LRP4 LTBP2	2.46e-04	249	123	8	IPR000742
Domain	Argonaute_N	AGO1 AGO4	2.56e-04	4	123	2	IPR032474
Domain	Argonaute_Mid_dom	AGO1 AGO4	2.56e-04	4	123	2	IPR032473
Domain	ArgoL2	AGO1 AGO4	2.56e-04	4	123	2	IPR032472
Domain	ArgoN	AGO1 AGO4	2.56e-04	4	123	2	PF16486
Domain	ArgoMid	AGO1 AGO4	2.56e-04	4	123	2	PF16487
Domain	ArgoL2	AGO1 AGO4	2.56e-04	4	123	2	PF16488
Domain	Ig_I-set	HSPG2 FLT4 PDGFRB FSTL5 IGDCC3 MFAP3L KIRREL3	2.65e-04	190	123	7	IPR013098
Domain	I-set	HSPG2 FLT4 PDGFRB FSTL5 IGDCC3 MFAP3L KIRREL3	2.65e-04	190	123	7	PF07679
Domain	EGF_1	HSPG2 TENM2 FAT1 CELSR1 FAT2 CELSR2 LRP4 LTBP2	2.88e-04	255	123	8	PS00022
Domain	-	PDK4 SMCHD1 MLH1	2.93e-04	20	123	3	3.30.565.10
Domain	EGF-like_CS	HSPG2 TENM2 FAT1 CELSR1 FAT2 CELSR2 LRP4 LTBP2	3.37e-04	261	123	8	IPR013032
Domain	HATPase_C	PDK4 SMCHD1 MLH1	3.40e-04	21	123	3	IPR003594
Domain	EGF_2	HSPG2 TENM2 FAT1 CELSR1 FAT2 CELSR2 LRP4 LTBP2	3.73e-04	265	123	8	PS01186
Domain	DUF1785	AGO1 AGO4	4.25e-04	5	123	2	SM01163
Domain	ASX_HYDROXYL	FAT1 CELSR1 CELSR2 LRP4 LTBP2	5.22e-04	100	123	5	PS00010
Domain	Growth_fac_rcpt_	HSPG2 FAT1 CELSR1 CELSR2 LRP4 LTBP2	5.87e-04	156	123	6	IPR009030
Domain	ConA-like_dom	HSPG2 COL18A1 FAT1 CELSR1 FAT2 CELSR2 CSPG4	6.23e-04	219	123	7	IPR013320
Domain	ArgoL1	AGO1 AGO4	6.34e-04	6	123	2	PF08699
Domain	ArgoL1	AGO1 AGO4	6.34e-04	6	123	2	IPR014811
Domain	EGF-type_Asp/Asn_hydroxyl_site	FAT1 CELSR1 CELSR2 LRP4 LTBP2	6.81e-04	106	123	5	IPR000152
Domain	IGc2	HSPG2 FLT4 PDGFRB FSTL5 IGDCC3 MFAP3L KIRREL3	9.42e-04	235	123	7	SM00408
Domain	Ig_sub2	HSPG2 FLT4 PDGFRB FSTL5 IGDCC3 MFAP3L KIRREL3	9.42e-04	235	123	7	IPR003598
Domain	EGF_LAM_2	HSPG2 CELSR1 CELSR2	9.94e-04	30	123	3	PS50027
Domain	EGF_LAM_1	HSPG2 CELSR1 CELSR2	9.94e-04	30	123	3	PS01248
Domain	PIWI	AGO1 AGO4	1.17e-03	8	123	2	PS50822
Domain	Piwi	AGO1 AGO4	1.17e-03	8	123	2	SM00950
Domain	Tyr_kinase_rcpt_3_CS	FLT4 PDGFRB	1.17e-03	8	123	2	IPR001824
Domain	RECEPTOR_TYR_KIN_III	FLT4 PDGFRB	1.17e-03	8	123	2	PS00240
Domain	Piwi	AGO1 AGO4	1.17e-03	8	123	2	PF02171
Domain	Piwi	AGO1 AGO4	1.17e-03	8	123	2	IPR003165
Domain	PAZ	AGO1 AGO4	1.50e-03	9	123	2	PS50821
Domain	PAZ	AGO1 AGO4	1.50e-03	9	123	2	SM00949
Domain	PAZ	AGO1 AGO4	1.50e-03	9	123	2	PF02170
Domain	PAZ_dom	AGO1 AGO4	1.50e-03	9	123	2	IPR003100
Domain	EGF_Lam	HSPG2 CELSR1 CELSR2	1.56e-03	35	123	3	SM00180
Domain	Laminin_EGF	HSPG2 CELSR1 CELSR2	1.56e-03	35	123	3	PF00053
Domain	Laminin_EGF	HSPG2 CELSR1 CELSR2	1.99e-03	38	123	3	IPR002049
Domain	GAIN_dom_N	CELSR1 CELSR2	2.28e-03	11	123	2	IPR032471
Domain	Laminin_G_1	HSPG2 CSPG4	2.28e-03	11	123	2	PF00054
Domain	GAIN	CELSR1 CELSR2	2.28e-03	11	123	2	PF16489
Domain	LDLRA_1	HSPG2 PKD1 LRP4	3.88e-03	48	123	3	PS01209
Domain	LDLRA_2	HSPG2 PKD1 LRP4	4.12e-03	49	123	3	PS50068
Domain	7tm_2	ADGRG1 CELSR1 CELSR2	4.36e-03	50	123	3	PF00002
Domain	G_PROTEIN_RECEP_F2_2	ADGRG1 CELSR1 CELSR2	4.36e-03	50	123	3	PS00650
Domain	GOLGA2L5	GOLGA6B GOLGA6A	6.14e-03	18	123	2	PF15070
Domain	HATPase_c	PDK4 MLH1	6.14e-03	18	123	2	SM00387
Domain	Golgin_A	GOLGA6B GOLGA6A	6.14e-03	18	123	2	IPR024858
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1	2.53e-09	6	127	4	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1	2.53e-09	6	127	4	25930072
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	HSPG2 MIA3 ERAP1 TM9SF4 SREBF1 ADGRG1 ELP6 P4HA3 NCAPH2 EDEM3 COL18A1 FAT1 CELSR1 CSGALNACT2 CELSR2 TMEM106C CSPG4 NUP210 PRSS21 LRP4 LTBP2	2.68e-09	1201	127	21	35696571
Pubmed	Perlecan maintains microvessel integrity in vivo and modulates their formation in vitro.	HSPG2 PDGFRB COL18A1 CSPG4	2.11e-08	9	127	4	23320101
Pubmed	Human transcription factor protein interaction networks.	HSPG2 RB1 BICRA SMCHD1 KLF3 ANKHD1 STAT2 FAT1 AGO1 SATB1 NFKBIA SYNE2 SMARCD2 ELF1 QSER1 MED17 SAP130 CAPRIN1 RAI2 TP53BP1 MYB	5.36e-08	1429	127	21	35140242
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MIA3 MAP6 GOLGA6B GOLGA6A TENM2 FRY AGO1 CELSR2 KIAA1217 SYNE2 DLG1 QSER1 CTNND2 CAPRIN1 TP53BP1 LRRC15	4.89e-07	963	127	16	28671696
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 HIVEP2 SH3RF1 ZNF628 BICRA SREBF1 ELP6 ANKHD1 WNK1 FAT1 CELSR1 CELSR2 CSPG4 PKD1 LRP4 ZFYVE26 MICAL3	6.06e-07	1105	127	17	35748872
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	MIA3 ARHGEF5 SREBF1 ANKHD1 DOCK5 PHKA2 PRSS21 MLH1 DLG1 AP1M1 MICAL3 QSER1 AQR	8.17e-07	650	127	13	38777146
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1	1.70e-06	24	127	4	32212159
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	MIA3 MAP6 GOLGA6B GOLGA6A ANKHD1 WNK1 DOCK5 AP1M1	2.21e-06	230	127	8	35449600
Pubmed	Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening.	FAT2 CELSR2 LRP4	3.93e-06	9	127	3	9693030
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	MIA3 ERAP1 TM9SF4 SMCHD1 ANKHD1 WNK1 EDEM3 COL18A1 FAT1 SYNE2 NUP210 PRSS21 MLH1 HERC4 CAPRIN1 AQR TP53BP1	5.24e-06	1297	127	17	33545068
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGA9 CELSR1 FAT2 CELSR2 PCDHGA8	6.90e-06	72	127	5	10380929
Pubmed	The spatiotemporal expression pattern of Syndecans in murine embryonic teeth.	HSPG2 TGFBR3 COL18A1 CSPG4	7.22e-06	34	127	4	32220631
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGA9 CELSR1 FAT2 CELSR2 PCDHGA8	9.60e-06	77	127	5	10835267
Pubmed	Chondrocytes respond to an altered heparan sulfate composition with distinct changes of heparan sulfate structure and increased levels of chondroitin sulfate.	HSPG2 COL18A1 CSGALNACT2 CSPG4	1.02e-05	37	127	4	32201365
Pubmed	Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis.	FLT4 PDGFRB CSPG4	1.02e-05	12	127	3	15322537
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGA9 CELSR1 FAT2 CELSR2 PCDHGA8	1.16e-05	80	127	5	10716726
Pubmed	Distinct clinical phenotype and genetic testing strategy for Lynch syndrome in China based on a large colorectal cancer cohort.	BRAF MLH1	1.32e-05	2	127	2	32030746
Pubmed	Cloning and characterization of a Golgin-related gene from the large-scale polymorphism linked to the PML gene.	GOLGA6B GOLGA6A	1.32e-05	2	127	2	11161787
Pubmed	Changes in pericytic expression of NG2 and PDGFRB and vascular permeability in the sensory circumventricular organs of adult mouse by osmotic stimulation.	PDGFRB CSPG4	1.32e-05	2	127	2	23629811
Pubmed	The Importance of AGO 1 and 4 in Post-Transcriptional Gene Regulatory Function of tRF5-GluCTC, an Respiratory Syncytial Virus-Induced tRNA-Derived RNA Fragment.	AGO1 AGO4	1.32e-05	2	127	2	33233493
Pubmed	HIPK1 interacts with c-Myb and modulates its activity through phosphorylation.	HIPK1 MYB	1.32e-05	2	127	2	19646965
Pubmed	Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer.	BRAF MLH1	1.32e-05	2	127	2	21102416
Pubmed	Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome.	BRAF MLH1	1.32e-05	2	127	2	20489114
Pubmed	SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated dimerization, causing detachment from chromatin early in T-cell apoptosis.	CASP6 SATB1	1.32e-05	2	127	2	11463840
Pubmed	Drosophila ATP6AP2/VhaPRR functions both as a novel planar cell polarity core protein and a regulator of endosomal trafficking.	CELSR1 CELSR2	1.32e-05	2	127	2	23292348
Pubmed	Androgen suppresses protein kinase D1 expression through fibroblast growth factor receptor substrate 2 in prostate cancer cells.	FRS2 PKD1	1.32e-05	2	127	2	28077787
Pubmed	A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders.	GOLGA6B GOLGA6A	1.32e-05	2	127	2	11509185
Pubmed	Lysine methylation-dependent binding of 53BP1 to the pRb tumor suppressor.	RB1 TP53BP1	1.32e-05	2	127	2	25049398
Pubmed	Human chromosome 15q11-q14 regions of rearrangements contain clusters of LCR15 duplicons.	GOLGA6B GOLGA6A	1.32e-05	2	127	2	11896453
Pubmed	Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.	HSPG2 CSPG4	1.32e-05	2	127	2	29462330
Pubmed	A brain-specific SGK1 splice isoform regulates expression of ASIC1 in neurons.	ASIC2 SGK1	1.32e-05	2	127	2	18334630
Pubmed	Structural maintenance of chromosomes flexible hinge domain containing 1 (SMCHD1) promotes non-homologous end joining and inhibits homologous recombination repair upon DNA damage.	SMCHD1 TP53BP1	1.32e-05	2	127	2	25294876
Pubmed	MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAFV600E mutation.	BRAF MLH1	1.32e-05	2	127	2	29304767
Pubmed	Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer.	BRAF MLH1	1.32e-05	2	127	2	18470905
Pubmed	Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study.	BRAF MLH1	1.32e-05	2	127	2	18718023
Pubmed	Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF.	BRAF CSPG4	1.32e-05	2	127	2	33649790
Pubmed	Quantitative evaluation of CpG island methylation in hyperplastic polyps.	BRAF MLH1	1.32e-05	2	127	2	19855373
Pubmed	Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans.	HSPG2 COL18A1	1.32e-05	2	127	2	21085708
Pubmed	Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.	HSPG2 COL18A1	1.32e-05	2	127	2	12514129
Pubmed	The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer.	BRAF MLH1	1.32e-05	2	127	2	18615680
Pubmed	Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review.	BRAF MLH1	1.32e-05	2	127	2	23880961
Pubmed	Characterization of the interaction between endostatin short peptide and VEGF receptor 3.	FLT4 COL18A1	1.32e-05	2	127	2	22512651
Pubmed	Additional complexity on human chromosome 15q: identification of a set of newly recognized duplicons (LCR15) on 15q11-q13, 15q24, and 15q26.	GOLGA6B GOLGA6A	1.32e-05	2	127	2	11156619
Pubmed	Association study of FLT4 and HYDIN single nucleotide polymorphisms with atrial septal defect susceptibility in the Han Chinese population of Southwest China.	FLT4 HYDIN	1.32e-05	2	127	2	38581027
Pubmed	Binding of an interferon-inducible protein (p202) to the retinoblastoma protein.	RB1 TP53BP1	1.32e-05	2	127	2	7890747
Pubmed	Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein.	RB1 ELF1	1.32e-05	2	127	2	8493578
Pubmed	Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel.	BRAF MLH1	1.32e-05	2	127	2	19127559
Pubmed	Neocentromeres in 15q24-26 map to duplicons which flanked an ancestral centromere in 15q25.	GOLGA6B GOLGA6A	1.32e-05	2	127	2	12915487
Pubmed	Effects of Echinococcus multilocularis miR-71 mimics on murine macrophage RAW264.7 cells.	AGO1 AGO4	1.32e-05	2	127	2	26995025
Pubmed	Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas.	RB1 BRAF	1.32e-05	2	127	2	33737597
Pubmed	Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.	BRAF MLH1	1.32e-05	2	127	2	22368298
Pubmed	Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability.	BRAF MLH1	1.32e-05	2	127	2	19424639
Pubmed	PRELP secreted from mural cells protects the function of blood brain barrier through regulation of endothelial cell-cell integrity.	HSPG2 PDGFRB CSPG4	1.32e-05	13	127	3	37936982
Pubmed	The potassium channel KCNJ13 is essential for smooth muscle cytoskeletal organization during mouse tracheal tubulogenesis.	GOLGA6B GOLGA6A CELSR1 CELSR2	1.55e-05	41	127	4	30022023
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HIPK1 TRO FSTL5 TENM2 MFAP3L KIRREL3 MICAL3 KIF17 AQR	1.98e-05	407	127	9	12693553
Pubmed	Prerequisite endocardial-mesenchymal transition for murine cardiac trabecular angiogenesis.	FLT4 PDGFRB TGFBR3	2.10e-05	15	127	3	37023750
Pubmed	Dynamic expression of chymotrypsin-like elastase 1 over the course of murine lung development.	PDGFRB CELA3A CSPG4	2.10e-05	15	127	3	24793170
Pubmed	Multiple mouse models of primary lymphedema exhibit distinct defects in lymphovenous valve development.	FLT4 PDGFRB CSPG4	2.57e-05	16	127	3	26542011
Pubmed	Tissue distribution and subcellular localization of the family of Kidney Ankyrin Repeat Domain (KANK) proteins.	FLT4 PDGFRB CSPG4	2.57e-05	16	127	3	33253712
Pubmed	Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects.	HSPG2 FREM1 CSPG4	2.57e-05	16	127	3	16880404
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	BICRA TRO TM9SF4 SMCHD1 FASTKD1 ADGRG1 NCAPH2 MFAP3L DOCK5 FAT1 CELSR2 TMEM106C DLG1 CAPRIN1	3.51e-05	1061	127	14	33845483
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	HSPG2 IL16 FREM1 COL18A1 CSPG4 LTBP2	3.58e-05	167	127	6	22159717
Pubmed	Regulation of the PDK4 isozyme by the Rb-E2F1 complex.	RB1 PDK4	3.96e-05	3	127	2	18667418
Pubmed	WNK1 activates SGK1 to regulate the epithelial sodium channel.	SGK1 WNK1	3.96e-05	3	127	2	16006511
Pubmed	Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation.	RB1 PKD1	3.96e-05	3	127	2	21900881
Pubmed	Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes.	FAT1 FAT2	3.96e-05	3	127	2	15744052
Pubmed	MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter.	RB1 MYB	3.96e-05	3	127	2	28973440
Pubmed	The lipid transporter HDLBP promotes hepatocellular carcinoma metastasis through BRAF-dependent epithelial-mesenchymal transition.	BRAF HDLBP	3.96e-05	3	127	2	36122630
Pubmed	BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes.	BRAF MLH1	3.96e-05	3	127	2	15782118
Pubmed	circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer.	STAT2 CAPRIN1	3.96e-05	3	127	2	36328987
Pubmed	The flamingo-related mouse Celsr family (Celsr1-3) genes exhibit distinct patterns of expression during embryonic development.	CELSR1 CELSR2	3.96e-05	3	127	2	11677057
Pubmed	Caspase 6 promotes innate immune activation by functional crosstalk between RIPK1-IκBα axis in liver inflammation.	CASP6 NFKBIA	3.96e-05	3	127	2	37828624
Pubmed	DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability.	BRAF MLH1	3.96e-05	3	127	2	24964857
Pubmed	Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins.	AGO1 AGO4	3.96e-05	3	127	2	19946268
Pubmed	Alternatively spliced proline-rich cassettes link WNK1 to aldosterone action.	SGK1 WNK1	3.96e-05	3	127	2	26241057
Pubmed	Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients.	BRAF MLH1	3.96e-05	3	127	2	18061181
Pubmed	Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.	BRAF MYB	3.96e-05	3	127	2	26810070
Pubmed	Regulation of a third conserved phosphorylation site in SGK1.	SGK1 WNK1	3.96e-05	3	127	2	19068477
Pubmed	Methylation of the retinoblastoma tumor suppressor by SMYD2.	RB1 L3MBTL1	3.96e-05	3	127	2	20870719
Pubmed	MLH1, BRAF and p53 - searching for significant markers to predict evolution towards adenocarcinoma in colonic sessile serrated lesions.	BRAF MLH1	3.96e-05	3	127	2	35673816
Pubmed	MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.	BRAF MLH1	3.96e-05	3	127	2	27438990
Pubmed	Potassium acts through mTOR to regulate its own secretion.	SGK1 WNK1	3.96e-05	3	127	2	31013253
Pubmed	CRISPR/Cas9 treatment causes extended TP53-dependent cell cycle arrest in human cells.	RB1 TP53BP1	3.96e-05	3	127	2	32687165
Pubmed	FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression.	PDGFRB FRS2	3.96e-05	3	127	2	19339244
Pubmed	Fibroblast-Derived STC-1 Modulates Tumor-Associated Macrophages and Lung Adenocarcinoma Development.	STC1 BRAF	3.96e-05	3	127	2	32579928
Pubmed	circFAT1(e2) Inhibits Cell Apoptosis and Facilitates Progression in Vascular Smooth Muscle Cells through miR-298/MYB Axis.	FAT1 MYB	3.96e-05	3	127	2	34938350
Pubmed	Assessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis.	BRAF MLH1	3.96e-05	3	127	2	22006538
Pubmed	Oligodendrogliogenic and neurogenic adult subependymal zone neural stem cells constitute distinct lineages and exhibit differential responsiveness to Wnt signalling.	PDGFRB CSPG4	3.96e-05	3	127	2	23644466
Pubmed	VEGF, VEGFR3, and PDGFRB protein expression is influenced by RAS mutations in medullary thyroid carcinoma.	FLT4 PDGFRB	3.96e-05	3	127	2	24754736
Pubmed	Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF.	RB1 BRAF	3.96e-05	3	127	2	21725359
Pubmed	Serum- and glucocorticoid-inducible kinase SGK phosphorylates and negatively regulates B-Raf.	SGK1 BRAF	3.96e-05	3	127	2	11410590
Pubmed	A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.	ERAP1 STAT2 NFKBIA	4.41e-05	19	127	3	20953190
Pubmed	An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis.	SREBF1 MED17 MYB	4.41e-05	19	127	3	16799563
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	MIA3 BMP2K MAP6 RTN4IP1 ANKHD1 WNK1 COL18A1 BRAF TMEM106C SLC25A38 DLG1 QSER1 HERC4 TP53BP1	4.43e-05	1084	127	14	11544199
Pubmed	Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	MAP6 FASTKD1 WAC KIRREL3 HYDIN	4.73e-05	107	127	5	11347906
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	BICRA SMCHD1 ZNF207 QRICH1 WAC SMARCD2 ELF1 QSER1 MED17 SAP130 CAPRIN1 TP53BP1 MYB HDLBP	5.33e-05	1103	127	14	34189442
Pubmed	Single Cell Sequencing Reveals Mechanisms of Persistent Truncus Arteriosus Formation after PDGFRα and PDGFRβ Double Knockout in Cardiac Neural Crest Cells.	PDGFRB GOLGA6B GOLGA6A	6.03e-05	21	127	3	36292593
Pubmed	PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα.	HSPG2 PDGFRB FREM1	6.03e-05	21	127	3	27856617
Interaction	KLK11 interactions	DYNC2I2 RB1 ERAP1 TGFBR3 FAT1	2.74e-06	36	125	5	int:KLK11
Interaction	FHL2 interactions	IL16 SH3RF1 BMP2K HIPK1 GOLGA6A QRICH1 WNK1 KIAA1217 ELF1 QSER1 SAP130 RAI2	6.71e-06	396	125	12	int:FHL2
Interaction	NFIX interactions	RB1 BICRA QRICH1 MLH1 SMARCD2 ELF1 QSER1 SAP130 HDLBP	1.23e-05	227	125	9	int:NFIX
Interaction	PML interactions	IL12RB1 RB1 HIPK1 SMCHD1 ZNF207 GOLGA6A QRICH1 STAT2 SATB1 GET3 SYNE2 MLH1 MED17 SAP130 CAPRIN1 TP53BP1 MYB HDLBP	1.81e-05	933	125	18	int:PML
Interaction	NXPH3 interactions	MIA3 ADGRG1 CELSR1 CELSR2 CSPG4	2.98e-05	58	125	5	int:NXPH3
Interaction	EMSY interactions	KLF3 NCAPH2 GET3 ELF1 QSER1 TP53BP1 MYB	3.39e-05	145	125	7	int:EMSY
Cytoband	4q32.3	SH3RF1 FSTL5 MFAP3L	1.16e-04	34	127	3	4q32.3
Cytoband	Ensembl 112 genes in cytogenetic band chr9q12	SPATA31A7 SPATA31A5	2.10e-04	8	127	2	chr9q12
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 TGFBR3 CSPG4	2.88e-06	7	80	3	570
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	HSPG2 FLT4 PDGFRB FSTL5 IGDCC3 MFAP3L KIRREL3	7.18e-06	161	80	7	593
GeneFamily	Cadherin related	CDHR5 FAT1 FAT2	5.42e-05	17	80	3	24
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR2	5.78e-05	3	80	2	913
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR2	5.78e-05	3	80	2	1189
GeneFamily	Argonaute/PIWI family	AGO1 AGO4	5.32e-04	8	80	2	408
Coexpression	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN	PHKA2 FRY PPP2R3A FAT2 ADSS2 GET3 MICAL3 POM121L1P CAPRIN1	5.59e-07	200	126	9	M5153
Coexpression	MARSHALL_VIRAL_INFECTION_RESPONSE_DN	SGK1 KLF3 NFKBIA MYB	1.10e-05	29	126	4	M1882
Coexpression	MARSHALL_VIRAL_INFECTION_RESPONSE_DN	SGK1 KLF3 NFKBIA MYB	1.65e-05	32	126	4	MM796
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPROGM	TRABD2B SH3RF1 MAP6 IGDCC3 FAT1 CELSR1 AGO1 ADSS2 HYDIN	1.83e-05	307	126	9	M39058
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING	HIPK1 RBIS ADGRG1 ZNF207 STC1 COL18A1 PPP2R3A CELSR2 SYNE2 ELF1	2.15e-05	394	126	10	MM3724
Coexpression	GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	IL12RB1 RB1 WNK1 TGFBR3 AGO4 TMEM106C MICAL3	4.99e-05	198	126	7	M6511
Coexpression	GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	IL16 DNAH2 KLF3 MFAP3L PHKA2 GET3 ZFYVE26	5.15e-05	199	126	7	M8636
Coexpression	GSE17721_CTRL_VS_CPG_24H_BMDC_DN	ZNF207 QRICH1 USP26 PPP2R3A TMEM106C TP53BP1 MYB	5.15e-05	199	126	7	M3772
Coexpression	GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	IL16 QRICH1 TGFBR3 BRAF SYNE2 ELF1 MED17	5.15e-05	199	126	7	M6660
Coexpression	GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN	HIPK1 TGFBR3 FRY AGO4 SATB1 PKD1 HERC4	5.15e-05	199	126	7	M5726
Coexpression	GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	FRS2 EDEM3 SMARCD2 ZFYVE26 MED17 SAP130 HDLBP	5.32e-05	200	126	7	M6993
Coexpression	SASSON_RESPONSE_TO_GONADOTROPHINS_UP	SGK1 ARHGEF5 ADGRG1 PHKA2 COL18A1	6.05e-05	86	126	5	M16587
Coexpression	SASSON_RESPONSE_TO_FORSKOLIN_UP	SGK1 ARHGEF5 ADGRG1 PHKA2 COL18A1	6.75e-05	88	126	5	M9869
Coexpression	WEI_MIR34A_TARGETS	PDGFRB ZNF207 STC1 NUP210 CTNND2 MYB	7.66e-05	146	126	6	M8617
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	HIVEP2 SH3RF1 TENM2 DOCK5 TGFBR3 FRY FAT1	7.67e-05	212	126	7	M39221
Coexpression	MARTINEZ_RB1_TARGETS_DN	RPGRIP1 TRO ADGRG1 TENM2 COL18A1 CELSR2 TMEM106C PKD1 SMARCD2 LTBP2 AQR	9.81e-05	569	126	11	M12701
Coexpression	RIGGINS_TAMOXIFEN_RESISTANCE_DN	MFAP3L WAC STC1 FAT1 DLG1 CTNND2 RAI2	9.95e-05	221	126	7	M15835
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4	RB1 TRO IGDCC3 CELSR2 SYNE2 NUP210 CTNND2	1.65e-06	98	123	7	Facebase_RNAseq_e10.5_Olfactory Pit_500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	RB1 TRO SMCHD1 IGDCC3 WNK1 WAC CELSR2 SYNE2 NUP210 DLG1 CTNND2 SAP130 AQR	4.22e-05	595	123	13	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000	RB1 TRO IGDCC3 ADGRG1 WNK1 TENM2 WAC AGO1 CELSR2 KIAA1217 SYNE2 NUP210 SLC25A38 CTNND2 MED17 TENT2 TP53BP1	4.99e-05	979	123	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRABD2B PDGFRB MAP6 P4HA3 GCNT4 MFAP3L FAT1 CSPG4 LTBP2	1.88e-09	174	127	9	a7ade7372e83edd4e3983e77f8417b51f0b47340
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRABD2B PDGFRB MAP6 GCNT4 MFAP3L FAT1 CSPG4 LTBP2 PCDHGA8	3.23e-09	185	127	9	a6cd90f8f30c7bdf66958cf403e73c193aa32f5e
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRABD2B PDGFRB MAP6 GCNT4 MFAP3L FAT1 CSPG4 LTBP2 PCDHGA8	3.23e-09	185	127	9	5053f932e2adfcf4d6faaecff2999ac53d8d7aa5
ToppCell	Basal_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	ASIC2 TRO TENM2 COL18A1 FAT1 FAT2 CELSR2 KIAA1217 LRP4	4.27e-09	191	127	9	a98915bad9a4a61dd4cbca798914849b805f4a19
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRABD2B PDGFRB GCNT4 MFAP3L FAT1 CSPG4 LTBP2 PCDHGA8	5.70e-08	183	127	8	0e8fb371d8eac777451c76f41d53577f5dfb740d
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRABD2B PDGFRB GCNT4 MFAP3L FAT1 CSPG4 LTBP2 PCDHGA8	5.70e-08	183	127	8	cbc3b00faa7e4e0dbbbc8ee105467c65241c7470
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 PDGFRB MAP6 TENM2 DOCK5 TGFBR3 KIRREL3 FRY	5.95e-08	184	127	8	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	Basal_cells\|World / lung cells shred on cell class, cell subclass, sample id	ASIC2 TENM2 FAT1 FAT2 CELSR2 KIAA1217 SYNE2 LRP4	1.01e-07	197	127	8	24360b660000bdfb999d58fbf4e29585a97e1785
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRABD2B ASIC2 FAT1 PPP2R3A SYNE2 MICAL3 HYDIN	8.08e-07	178	127	7	544379f5a6145429762258d426b876bb36c112f5
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	PDK4 TENM2 FRY PPP2R3A DLG1 MICAL3 CTNND2	9.37e-07	182	127	7	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 PDGFRB MAP6 TENM2 DOCK5 TGFBR3 FRY	9.72e-07	183	127	7	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB MAP6 TENM2 DOCK5 TGFBR3 KIRREL3 FRY	9.72e-07	183	127	7	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 PDGFRB MAP6 TENM2 DOCK5 TGFBR3 FRY	9.72e-07	183	127	7	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB MAP6 TENM2 DOCK5 TGFBR3 KIRREL3 FRY	9.72e-07	183	127	7	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB MAP6 TENM2 DOCK5 TGFBR3 KIRREL3 FRY	1.05e-06	185	127	7	b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 PDGFRB TRO P4HA3 FAT1 CSPG4 LTBP2	1.34e-06	192	127	7	2cc712186e37fb21a964c032765c36a8b4a852cf
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	SMCHD1 KLF3 STAT2 BRAF NFKBIA ELF1 TENT2	1.39e-06	193	127	7	7256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B SH3RF1 FAT1 PPP2R3A CELSR1 SYNE2 MICAL3	1.44e-06	194	127	7	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	facs-Skin-Telogen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRABD2B SH3RF1 MAP6 TENM2 COL18A1 CSPG4 LTBP2	1.54e-06	196	127	7	c936014125b2ed5f796221b74acb77b8f8359875
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	SMCHD1 KLF3 STAT2 BRAF NFKBIA ELF1 TENT2	1.59e-06	197	127	7	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	SMCHD1 KLF3 STAT2 BRAF NFKBIA ELF1 TENT2	1.64e-06	198	127	7	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SMCHD1 KLF3 STAT2 BRAF NFKBIA ELF1 TENT2	1.64e-06	198	127	7	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	lymphoid-NK_cell-NK_cell\|NK_cell / Lineage, cell class and subclass	HIPK1 SMCHD1 ADGRG1 ZNF207 WAC SYNE2 ELF1	1.70e-06	199	127	7	945fbf5845403a8b22d04963f50ad69c414b6153
ToppCell	medial-2-Endothelial-Capillary_Intermediate_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FLT4 PDK4 SGK1 STC1 TGFBR3 FRY KIAA1217	1.76e-06	200	127	7	a8adf5902540f6bb15b72efbb9c389b59d67e001
ToppCell	medial-Endothelial-Capillary_Intermediate_1\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FLT4 PDK4 SGK1 STC1 TGFBR3 FRY KIAA1217	1.76e-06	200	127	7	3ef7b7728615710c691aed8977e2582f19692cf9
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 TRABD2B PDGFRB PDK4 FREM1 TGFBR3 LTBP2	1.76e-06	200	127	7	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	medial-Endothelial-Capillary_Intermediate_1-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FLT4 PDK4 SGK1 STC1 TGFBR3 FRY KIAA1217	1.76e-06	200	127	7	707148e01e961097819a05437a842b7d3bf72b0a
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ASIC2 STC1 FAT1 LRP4 LTBP2 RAI2	5.99e-06	157	127	6	b9d04ee417c0d8ea0801d10f1c54e138587009fd
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRABD2B KIRREL3 FAT1 SYNE2 MICAL3 HYDIN	8.82e-06	168	127	6	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB MAP6 TENM2 DOCK5 TGFBR3 KIRREL3	1.01e-05	172	127	6	6c17a1e586a72d1bd80c20c06370429c61dc9f85
ToppCell	COVID-19-Heart-Neuronal\|Heart / Disease (COVID-19 only), tissue and cell type	TRABD2B MFAP3L DOCK5 KIRREL3 KIAA1217 CTNND2	1.04e-05	173	127	6	6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCell	droplet-Lung-nan-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3RF1 PDGFRB MAP6 CSPG4 LRP4 LTBP2	1.19e-05	177	127	6	65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a
ToppCell	droplet-Lung-nan-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3RF1 PDGFRB MAP6 CSPG4 LRP4 LTBP2	1.19e-05	177	127	6	8684d47a547e2a06496f15e8da0200ecddc431e0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP6 TENM2 DOCK5 TGFBR3 KIRREL3 FRY	1.27e-05	179	127	6	7394e77e665bf16d3733df91bb12907be460ab44
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	TRABD2B PDGFRB PDK4 COL18A1 FAT1 CSPG4	1.27e-05	179	127	6	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	renal_papilla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 PDK4 TGFBR3 FRY KIAA1217 LRP4	1.31e-05	180	127	6	49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B SH3RF1 ASIC2 FREM1 FRY PPP2R3A	1.35e-05	181	127	6	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	COVID-19-kidney-Podocyte\|kidney / Disease (COVID-19 only), tissue and cell type	PDGFRB MAP6 TENM2 DOCK5 TGFBR3 FRY	1.43e-05	183	127	6	fb5e2a31b560126e1c04a386c24c365901c60ad7
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRABD2B PDGFRB P4HA3 TGFBR3 LRP4 LTBP2	1.43e-05	183	127	6	06a68fa2be36448064f4668be24a5b85ad85c6e8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB MAP6 TENM2 DOCK5 TGFBR3 FRY	1.43e-05	183	127	6	612d93df03252d4d2ccdce5a9bc162cfd9172a1a
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRABD2B PDGFRB TRO FAT1 CSPG4 LTBP2	1.48e-05	184	127	6	55dde9c4eebac2a33788c1ff1d8fe312d150fad4
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRABD2B PDGFRB TRO FAT1 CSPG4 LTBP2	1.48e-05	184	127	6	7128a2be291544d3df3ed6c80f21ddda8437dcba
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRABD2B PDGFRB TRO FAT1 CSPG4 LTBP2	1.48e-05	184	127	6	d14238f7b0b55a4c8d7040bea854bd221a66ac30
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB MAP6 TENM2 DOCK5 TGFBR3 FRY	1.53e-05	185	127	6	9197f074e769d54031ec41abfc65fcc0c6552c7e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB MAP6 TENM2 DOCK5 TGFBR3 FRY	1.53e-05	185	127	6	ce7d62394b09c26ca65b8cdb280afec5e25bbb62
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HIPK1 ADGRG1 KLF3 TGFBR3 NFKBIA SYNE2	1.62e-05	187	127	6	6981b856187a2e689260ecb7d0a1193a374ee9b9
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRABD2B PDGFRB TGFBR3 COL18A1 CSPG4 LTBP2	1.62e-05	187	127	6	976b74d081b7fba8620768613cc26f9262cd7b16
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	PDGFRB TM9SF4 COL18A1 ELF1 LTBP2 LRRC15	1.67e-05	188	127	6	14bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FSTL5 TGFBR3 COL18A1 KIRREL3 FAT1 MYB	1.77e-05	190	127	6	2f54da2bee411f8868348a4c37034184b8f58a89
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SGK1 FSTL5 FREM1 COL18A1 KIRREL3 FAT1	1.77e-05	190	127	6	3b8d1e66ae68c1eee64095e75195d76d97e24026
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SGK1 FSTL5 FREM1 COL18A1 KIRREL3 FAT1	1.77e-05	190	127	6	dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B ADGRG1 PPP2R3A CELSR1 SYNE2 MICAL3	1.83e-05	191	127	6	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B ADGRG1 PPP2R3A CELSR1 SYNE2 MICAL3	1.83e-05	191	127	6	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM2 CELSR1 FAT2 CSPG4 NFKBIA SYNE2	1.83e-05	191	127	6	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDGFRB MAP6 P4HA3 TGFBR3 CSPG4 LTBP2	1.83e-05	191	127	6	fd8331c7abdd999f55ba43d307945c6abfccbf84
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TENM2 FREM1 STC1 DOCK5 FAT1 MICAL3	1.88e-05	192	127	6	4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SGK1 FSTL5 P4HA3 FREM1 COL18A1 FAT1	1.88e-05	192	127	6	342842378c20267c5044bdd622515e8b9f895623
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SGK1 FSTL5 FREM1 COL18A1 FAT1 MYB	1.94e-05	193	127	6	294cb5b580bb83fe0eb04f112d5507aac35d4d44
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	PDK4 TENM2 FRY PPP2R3A MICAL3 CTNND2	1.94e-05	193	127	6	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SGK1 FSTL5 FREM1 COL18A1 FAT1 MYB	1.94e-05	193	127	6	3d3c45d5ff6f3396a1990615aae9fe176e799994
ToppCell	facs-Thymus-nan-3m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF207 WAC SATB1 SMARCD2 CAPRIN1 MYB	1.99e-05	194	127	6	f1661f9f2439fca5c1012c693b0744c4e3b90a9b
ToppCell	facs-Thymus-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF207 WAC SATB1 SMARCD2 CAPRIN1 MYB	1.99e-05	194	127	6	cda1b197efb199330ea7ab25a7cee22cae22589d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B SH3RF1 ADGRG1 COL18A1 FAT1 PPP2R3A	1.99e-05	194	127	6	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	facs-Thymus-nan-3m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF207 WAC SATB1 SMARCD2 CAPRIN1 MYB	1.99e-05	194	127	6	66c056232ac216780acf4cc8ea325bd8ed1909c9
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	P4HA3 STC1 TGFBR3 LTBP2 RAI2 LRRC15	2.05e-05	195	127	6	2514c1f23424b5fc664d326d31ffd22bafe74ef8
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SH3RF1 FAT1 CELSR1 KIAA1217 SYNE2 CTNND2	2.05e-05	195	127	6	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRABD2B SH3RF1 TENM2 COL18A1 CSPG4 LTBP2	2.11e-05	196	127	6	90edf61116ffcb4f8b6be3d0a05732d59b0a87d5
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ASIC2 TENM2 FAT1 FAT2 CELSR2 SYNE2	2.11e-05	196	127	6	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	FLT4 SGK1 TGFBR3 FRY KIAA1217 SYNE2	2.11e-05	196	127	6	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B PDK4 FAT1 PPP2R3A SYNE2 HYDIN	2.17e-05	197	127	6	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRABD2B PDGFRB PDK4 COL18A1 CSPG4 MICAL3	2.24e-05	198	127	6	bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCell	Epithelial_cells-Basal_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	ASIC2 TENM2 COL18A1 FAT2 LRP4 LTBP2	2.24e-05	198	127	6	4235005c49fc2b29ad3a0ee6b608f0109d04f775
ToppCell	(0)_NK_cells-(0)_NK_FCGR3Apos\|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PDGFRB ADGRG1 KLF3 DOCK5 TGFBR3 SYNE2	2.24e-05	198	127	6	eba39656c6f699ab297b652ded8cb9727b49593c
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGEF5 TENM2 FAT1 FAT2 ARHGEF35 KIAA1217	2.24e-05	198	127	6	fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ASIC2 TRO KIAA1217 CSPG4 LRP4 HYDIN	2.30e-05	199	127	6	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 TRABD2B PDK4 TGFBR3 FRY CSPG4	2.37e-05	200	127	6	b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCell	10x5'v1-week_14-16-Endothelial-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 FLT4 PDK4 P4HA3 STC1 KIAA1217	2.37e-05	200	127	6	2488aa12970a43a5af352e2c36c73884d73a1cc5
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 TRABD2B PDGFRB FREM1 TGFBR3 LTBP2	2.37e-05	200	127	6	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	HIVEP2 SMCHD1 ADGRG1 KIAA1217 NFKBIA SYNE2	2.37e-05	200	127	6	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 TRABD2B PDK4 TGFBR3 FRY CSPG4	2.37e-05	200	127	6	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PDGFRB FSTL5 TGFBR3 FAT1 LRP4 LTBP2	2.37e-05	200	127	6	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	distal-2-Endothelial-Capillary_Intermediate_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FLT4 SGK1 STC1 TGFBR3 FRY KIAA1217	2.37e-05	200	127	6	7a99f28670ffb8ece7873d8a9bcd2a3936d0255d
ToppCell	Bronchial-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 TRABD2B PDK4 TGFBR3 FRY CSPG4	2.37e-05	200	127	6	b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47
ToppCell	distal-Endothelial-Capillary_Intermediate_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FLT4 SGK1 STC1 TGFBR3 FRY KIAA1217	2.37e-05	200	127	6	43bc48413b100a06f8edd9acd812296788fcbf5b
ToppCell	10x5'v1-week_14-16-Endothelial-stroma-sinusoidal_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 FLT4 PDK4 P4HA3 STC1 KIAA1217	2.37e-05	200	127	6	ae429f2de652cc1976e63644781197e9ce0e70c8
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	SMCHD1 KLF3 BRAF NFKBIA SYNE2 ELF1	2.37e-05	200	127	6	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	10x5'v1-week_14-16-Endothelial\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 FLT4 PDK4 P4HA3 STC1 KIAA1217	2.37e-05	200	127	6	e786544cf6f891550c4be55ebb4928c92297b504
ToppCell	distal-Endothelial-Capillary_Intermediate_1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FLT4 SGK1 STC1 TGFBR3 FRY KIAA1217	2.37e-05	200	127	6	4d6714d48738cdee7d535923f6dd2431e5304741
ToppCell	Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 TRABD2B PDK4 TGFBR3 FRY CSPG4	2.37e-05	200	127	6	7c673ad0ea503ebd196579684d25d5f9e6a41030
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2\|Cerebellum / BrainAtlas - Mouse McCarroll V32	BICRA RBIS ZNF207 CCDC168 CSPG4	4.59e-05	137	127	5	9324b55eac55e0cc1e8e450a4b5374d12e9587a3
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	BICRA RBIS ZNF207 CCDC168 CSPG4	4.59e-05	137	127	5	032f8409d0d179e254c8ff632afbda78852a9889
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	BICRA RBIS ZNF207 CCDC168 CSPG4	4.59e-05	137	127	5	265a4a50e48b13c8b3b0730f818235f71fbd6baa
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B SH3RF1 ZNF628 ADGRG1 CCDC17	5.63e-05	143	127	5	990844ca674d30b2924c74b45bed4fdfb8463fa7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B SH3RF1 ASIC2 FREM1 PPP2R3A	7.52e-05	152	127	5	eee86b508b8f140ea44e21d8c04c409a7b689e39
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	FLT4 PCDHGA9 P4HA3 LTBP2 CTNND2	8.00e-05	154	127	5	511923b27469ea20f8bd82a9ec27119a6e884644
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FLT4 RNF17 CTRL HYDIN	8.25e-05	155	127	5	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	severe_COVID-19-pDC\|World / disease group, cell group and cell class (v2)	HSPG2 SH3RF1 PPP2R3A KIF17 MYB	9.30e-05	159	127	5	e1c48c4ceda116826819ff9adeed7bad6a58844d
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAP6 GCNT4 FREM1 METTL21A LTBP2	1.17e-04	167	127	5	55c3c68af269fcf40f2b080ae4489523609ad388
ToppCell	facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 TRABD2B TENM2 COL18A1 CSPG4	1.17e-04	167	127	5	78909f685ccd1321064eb0887caf9263e0e54879
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 RNF17 NFKBIA LTBP2 HYDIN	1.24e-04	169	127	5	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
Drug	Rolipram [61413-54-5]; Up 200; 14.6uM; PC3; HT_HG-U133A	IL16 RB1 WNK1 STAT2 MFAP3L STC1 PRDM10 LRP4 RAI2	1.07e-06	193	123	9	6730_UP
Drug	(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A	HSPG2 FLT4 BMP2K NCAPH2 PHKA2 EDEM3 ELF1 HERC4 AQR	1.27e-06	197	123	9	4363_DN
Drug	Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; HL60; HT_HG-U133A	IL12RB1 HSPG2 FLT4 BMP2K ERAP1 PHKA2 DLG1 MYB HDLBP	1.33e-06	198	123	9	3024_DN
Drug	Sorafenib	FLT4 PDGFRB BRAF	5.30e-06	7	123	3	DB00398
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	HSPG2 MIA3 HIPK1 ADGRG1 EDEM3 LTBP2 HERC4 DDX28	9.22e-06	190	123	8	4362_DN
Drug	MS-275; Down 200; 10uM; PC3; HT_HG-U133A	HIPK1 ZNF207 WAC PRDM10 SLC25A38 ZFYVE26 SAP130 CAPRIN1	1.03e-05	193	123	8	7084_DN
Drug	H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A	HSPG2 BMP2K HIPK1 WNK1 TGFBR3 EDEM3 NUP210 HERC4	1.07e-05	194	123	8	6921_UP
Drug	Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	FLT4 RB1 ERAP1 KLF3 NCAPH2 WNK1 MFAP3L STC1	1.16e-05	196	123	8	2874_DN
Drug	Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; PC3; HT_HG-U133A	RB1 ERAP1 WNK1 AGO4 L3MBTL1 LRP4 LRRC15 MYB	1.20e-05	197	123	8	4186_UP
Drug	Sulfachloropyridazine [80-32-0]; Down 200; 14uM; MCF7; HT_HG-U133A	IL12RB1 HIVEP2 FRS2 NCAPH2 MFAP3L PHKA2 ZFYVE26 QSER1	1.24e-05	198	123	8	6046_DN
Drug	Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; HL60; HT_HG-U133A	BMP2K ERAP1 TM9SF4 CASP6 PHKA2 DLG1 ZFYVE26 HERC4	1.29e-05	199	123	8	3079_DN
Drug	Avermectin B1 [71751-41-2]; Up 200; 4.8uM; PC3; HT_HG-U133A	FLT4 PDGFRB ERAP1 MFAP3L AGO4 L3MBTL1 CTNND2 DDX28	1.29e-05	199	123	8	5864_UP
Drug	Lc 6	FLT4 RB1 PDGFRB MLH1	6.38e-05	40	123	4	CID000106696
Drug	Gossypol [303-45-7]; Up 200; 7.8uM; HL60; HT_HG-U133A	HIVEP2 PDK4 KLF3 DOCK5 COL18A1 NFKBIA LRRC15	6.94e-05	186	123	7	2202_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A	HSPG2 FLT4 ERAP1 TM9SF4 NCAPH2 PRDM10 NFKBIA	7.18e-05	187	123	7	2669_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	HIPK1 WNK1 EDEM3 PPP2R3A L3MBTL1 NUP210 ELF1	8.19e-05	191	123	7	6644_DN
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A	SGK1 ADGRG1 WNK1 MFAP3L HERC4 DDX28 MYB	8.47e-05	192	123	7	3400_DN
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A	FLT4 RB1 BICRA NCAPH2 MFAP3L HERC4 AQR	8.47e-05	192	123	7	2865_DN
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; HL60; HG-U133A	SGK1 HIPK1 TM9SF4 WAC EDEM3 CTRL CAPRIN1	8.75e-05	193	123	7	1412_DN
Drug	Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A	NCAPH2 WNK1 TGFBR3 EDEM3 DLG1 CTNND2 DDX28	9.03e-05	194	123	7	3377_DN
Drug	Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; HL60; HT_HG-U133A	FLT4 RB1 CASP6 TMEM106C MICAL3 LTBP2 KIF17	9.03e-05	194	123	7	3021_DN
Drug	F0447-0125; Up 200; 10uM; MCF7; HT_HG-U133A	IL12RB1 MIA3 PDGFRB PDK4 NCAPH2 SATB1 LTBP2	9.03e-05	194	123	7	6424_UP
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	HSPG2 NCAPH2 RNF17 LRP4 LTBP2 HERC4 HDLBP	9.33e-05	195	123	7	2805_UP
Drug	Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	FLT4 RB1 KLF3 NCAPH2 MFAP3L DDX28 MYB	9.33e-05	195	123	7	2884_DN
Drug	Indomethacin [53-86-1]; Down 200; 11.2uM; HL60; HT_HG-U133A	BMP2K BICRA SREBF1 NCAPH2 AGO4 CELSR2 MICAL3	9.63e-05	196	123	7	2377_DN
Drug	Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	WNK1 MFAP3L STC1 PPP2R3A BRAF LTBP2 AQR	9.63e-05	196	123	7	5670_DN
Drug	Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A	IL12RB1 FLT4 KLF3 NCAPH2 STAT2 MFAP3L PPP2R3A	9.63e-05	196	123	7	3878_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	IL12RB1 TM9SF4 KLF3 NCAPH2 DOCK5 MICAL3 MYB	9.94e-05	197	123	7	6143_DN
Drug	Tenoxicam [59804-37-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A	HSPG2 HIVEP2 BMP2K NCAPH2 PPP2R3A QSER1 CTNND2	9.94e-05	197	123	7	2860_DN
Drug	Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; MCF7; HT_HG-U133A	FLT4 HIVEP2 BICRA WNK1 PPP2R3A QSER1 CAPRIN1	9.94e-05	197	123	7	3443_DN
Drug	Norethynodrel [68-23-5]; Down 200; 13.4uM; PC3; HT_HG-U133A	BMP2K BICRA NCAPH2 PHKA2 NUP210 DDX28 HDLBP	1.03e-04	198	123	7	1818_DN
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; HL60; HT_HG-U133A	HIVEP2 ERAP1 NCAPH2 DOCK5 PHKA2 TGFBR3 BRAF	1.03e-04	198	123	7	1868_DN
Drug	Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; HL60; HT_HG-U133A	IL16 BMP2K CASP6 NCAPH2 WNK1 PHKA2 HDLBP	1.03e-04	198	123	7	1329_DN
Drug	Sulfisoxazole [127-69-5]; Up 200; 15uM; PC3; HT_HG-U133A	HSPG2 RB1 PDGFRB BICRA TRO L3MBTL1 KIF17	1.03e-04	198	123	7	4661_UP
Drug	Cefotetan [69712-56-7]; Down 200; 7uM; HL60; HT_HG-U133A	HSPG2 HIVEP2 BICRA TM9SF4 NCAPH2 SATB1 NUP210	1.06e-04	199	123	7	1319_DN
Drug	Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A	IL12RB1 BMP2K PDK4 NCAPH2 STC1 PHKA2 HERC4	1.06e-04	199	123	7	5634_DN
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	PDK4 NCAPH2 WNK1 CELSR2 NUP210 QSER1 CTNND2	1.06e-04	199	123	7	3759_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	HIVEP2 SGK1 NCAPH2 STC1 TGFBR3 CTNND2 HERC4	1.06e-04	199	123	7	5542_DN
Drug	Chlorthalidone [77-36-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	BMP2K PDK4 KLF3 MFAP3L PHKA2 NUP210 AQR	1.09e-04	200	123	7	7152_UP
Drug	Epiandrosterone [481-29-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A	FLT4 MFAP3L STC1 PHKA2 TGFBR3 PPP2R3A CTNND2	1.09e-04	200	123	7	5687_DN
Disease	severe acute respiratory syndrome, COVID-19	ADGRG1 TENM2 TGFBR3 KIRREL3 ADSS2 KIAA1217 NUP210 LTBP2 MYB	6.61e-05	447	115	9	EFO_0000694, MONDO_0100096
Disease	glioblastoma (is_implicated_in)	RB1 PDGFRB NFKBIA	1.10e-04	24	115	3	DOID:3068 (is_implicated_in)
Disease	Milroy Disease	FLT4 CELSR1	1.49e-04	5	115	2	C1704423
Disease	alkaline phosphatase measurement	HSPG2 KLF3 WAC EDEM3 KIRREL3 CELA3A PKD1 ELF1 MICAL3 LTBP2 KIF17 TP53BP1 HDLBP	1.67e-04	1015	115	13	EFO_0004533
Disease	prostate cancer (implicated_via_orthology)	PDGFRB P4HA3 HDLBP	2.89e-04	33	115	3	DOID:10283 (implicated_via_orthology)
Disease	thyroxine measurement	ASIC2 SGK1 MFAP3L KIRREL3	3.17e-04	83	115	4	EFO_0005130
Disease	Giant Cell Glioblastoma	FAT1 NFKBIA CTNND2 TP53BP1	3.32e-04	84	115	4	C0334588
Disease	colorectal adenocarcinoma (is_implicated_in)	IL16 BRAF CCDC17	3.45e-04	35	115	3	DOID:0050861 (is_implicated_in)
Disease	stanniocalcin-1 measurement	STC1 CELSR2	4.15e-04	8	115	2	EFO_0020753
Disease	HDL cholesterol change measurement, response to simvastatin, response to fenofibrate	TGFBR3 CELSR1	4.15e-04	8	115	2	EFO_0007805, GO_1901557, GO_1903491
Disease	Attached earlobe	HIVEP2 KIAA1217	4.15e-04	8	115	2	HP_0009907
Disease	amyloid-beta measurement	ASIC2 TENM2 KIRREL3 KIAA1217 MICAL3 CTNND2 TENT2	4.96e-04	355	115	7	EFO_0005194
Disease	cervix uteri carcinoma in situ (is_marker_for)	RB1 MLH1 DLG1	5.93e-04	42	115	3	DOID:8991 (is_marker_for)
Disease	triglycerides in large LDL measurement	CELSR2 SYNE2 TP53BP1	6.35e-04	43	115	3	EFO_0022319
Disease	Gastrointestinal Stromal Tumors	RB1 HIPK1 BRAF	9.89e-04	50	115	3	C0238198
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	CELSR2 SYNE2 LRP4 TP53BP1	1.31e-03	121	115	4	EFO_0008595, EFO_0020943
Disease	thalamus volume change measurement	ASIC2 FAT1	1.33e-03	14	115	2	EFO_0021496
Disease	triglycerides in LDL measurement	CELSR2 SYNE2 TP53BP1	1.38e-03	56	115	3	EFO_0022320
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	CELSR2 SYNE2 LRP4 TP53BP1	1.57e-03	127	115	4	EFO_0008595, EFO_0020947
Disease	renal cell carcinoma (is_marker_for)	RB1 PDGFRB FRS2 MLH1	1.61e-03	128	115	4	DOID:4450 (is_marker_for)
Disease	Brain Ischemia	IL12RB1 RB1 NFKBIA	1.68e-03	60	115	3	C0007786
Disease	Cerebral Ischemia	IL12RB1 RB1 NFKBIA	1.68e-03	60	115	3	C0917798
Disease	Intellectual Disability	HIVEP2 PDGFRB QRICH1 WAC COL18A1 FRY AGO1	1.88e-03	447	115	7	C3714756
Disease	Sjogren's syndrome (implicated_via_orthology)	SATB1 NFKBIA	1.97e-03	17	115	2	DOID:12894 (implicated_via_orthology)
Disease	alcoholic hepatitis (biomarker_via_orthology)	SREBF1 NFKBIA	2.21e-03	18	115	2	DOID:12351 (biomarker_via_orthology)
Disease	Adrenocortical carcinoma	RB1 BRAF	2.21e-03	18	115	2	C0206686
Disease	sporadic amyotrophic lateral sclerosis	ASIC2 METTL21A ZFYVE26 CTNND2	2.23e-03	140	115	4	EFO_0001357
Disease	Alzheimer disease, age at onset	HSPG2 SH3RF1 SGK1 WAC COL18A1 FAT1	2.30e-03	343	115	6	EFO_0004847, MONDO_0004975
Disease	schizophrenia (implicated_via_orthology)	HIVEP2 PDGFRB MAP6	2.40e-03	68	115	3	DOID:5419 (implicated_via_orthology)
Disease	coronary artery disease	MIA3 HIVEP2 MAP6 ASIC2 SREBF1 QRICH1 DOCK5 PPP2R3A CELSR2 KIAA1217 NUP210 SAP130	2.44e-03	1194	115	12	EFO_0001645
Disease	hydrocephalus (implicated_via_orthology)	CELSR2 HYDIN	2.47e-03	19	115	2	DOID:10908 (implicated_via_orthology)
Disease	urate measurement, bone density	ASIC2 FSTL5 QRICH1 TENM2 FREM1 DOCK5 KIRREL3 CTNND2	2.98e-03	619	115	8	EFO_0003923, EFO_0004531
Disease	gestational age, birth measurement	PPP2R3A TMEM106C	3.01e-03	21	115	2	EFO_0005112, EFO_0006921
Disease	Sarcoma	FLT4 RB1	3.01e-03	21	115	2	C1261473
Disease	coronary atherosclerosis measurement, traffic air pollution measurement	CAPRIN1 FCAMR	3.01e-03	21	115	2	EFO_0007908, EFO_0007938
Disease	response to bronchodilator, FEV/FEC ratio	RB1 ASIC2 ARHGEF5 PNPLA5 TENM2 DOCK5 FAT2 NUP210 TENT2	3.12e-03	766	115	9	EFO_0004713, GO_0097366
Disease	calcium measurement	ASIC2 SGK1 DNAH2 SREBF1 MFAP3L KIRREL3 CELSR2 SYNE2	3.25e-03	628	115	8	EFO_0004838
Disease	e-selectin measurement	KIRREL3 CELSR2	3.31e-03	22	115	2	EFO_0004575
Disease	PR interval	HSPG2 ASIC2 FAT1 NFKBIA SYNE2 DLG1 CTNND2	3.32e-03	495	115	7	EFO_0004462
Disease	Glioblastoma	FAT1 CTNND2 TP53BP1	3.68e-03	79	115	3	C0017636

Protein segments in the cluster

Peptide	Gene	Start	Entry
IFLDRVHQNEVQPPV	USP26	96	Q9BXU7
PAHLQQVALPLVTVN	CTRL	171	P40313
APNVHINTIEPVNID	BRAF	366	P15056
ATEPQRAAVVPQEHQ	CCDC17	51	Q96LX7
RAAVVPQEHQGVPQE	CCDC17	56	Q96LX7
VHVVQPVQAVPEGEA	ELF1	386	P32519
QVPVVVSPRNQQLHT	ELF1	426	P32519
IQPVNDHAPVQTISR	CSPG4	1011	Q6UVK1
QESQGLLHPQEVQVL	ARHGEF5	216	Q12774
PPQEHISPQITNEVI	DLG1	116	Q12959
LVPHQRSAVFQQPVI	AGO1	576	Q9UL18
QESQGLLHPQEVQVL	ARHGEF35	216	A5YM69
TANNVEIHIPVPNDA	AP1M1	306	Q9BXS5
PHQEPTVVNQIVPLS	TENT2	96	Q6PIY7
HNVKVTVEDPALQIP	AQR	731	O60306
TVHILLVDQNDNPPV	CELSR1	1086	Q9NYQ6
TLATPPDHVVVFNVQ	CELSR2	1156	Q9HCU4
VDVVFQAQKEPHPLQ	ELP6	91	Q0PNE2
INNVLVPHQRPSVFQ	AGO4	566	Q9HCK5
ENTNVTEPLVDIHVP	CDHR5	41	Q9HBB8
ITPHQSQQSQPVELD	BMP2K	1136	Q9NSY1
VHSESRLAQPNQVPV	CAPRIN1	411	Q14444
PAEDIKHNQVSAQPV	CTNND2	1131	Q9UQB3
VQIHSQSEPPFIQEL	ASIC2	246	Q16515
NLDEEVNVIPPHTPV	RB1	361	P06400
TQGPVQLPVVLEQHV	RAI2	116	Q9Y5P3
ETNQAPLVVEVHPAR	HSPG2	1671	P98160
PEEHIPHQQIQAQLV	QRICH1	186	Q2TAL8
DPQQQSITHIAIPQE	QRICH1	321	Q2TAL8
TLDQQHIETPGQNIP	QSER1	941	Q2KHR3
EGSPHDNPTVQQIVQ	GOLGA6A	671	Q9NYA3
TQIALHVADINDNPP	PCDHGA8	436	Q9Y5G5
ESPNHVVAEAVIQRP	P4HA3	276	Q7Z4N8
HQENQPSLTPIEVIV	PDK4	266	Q16654
PVWNQQEVEIHIPIT	NUP210	441	Q8TEM1
EVVDVNENLHPPVFS	FAT1	1021	Q14517
PQALLQENHPSVIVQ	KLF3	226	P57682
QPQQIAIKVSVHPQS	MFAP3L	311	O75121
EIHVNVEFQGLIQPP	MICAL3	176	Q7RTP6
VQAPAEFVQHPQSIS	IGDCC3	326	Q8IVU1
HEQTPLPAAQAQVQA	MAP6	256	Q96JE9
NSLVPVQDQHQPIII	HIPK1	881	Q86Z02
VQDQHQPIIIPDTPS	HIPK1	886	Q86Z02
QQKFIAHVPVPSQQE	ISY1	236	Q9ULR0
AHVPVPSQQEIEEAL	ISY1	241	Q9ULR0
SIHVQEPQEPSLQDA	KIAA1109	4821	Q2LD37
KEQQLPPRAVQIVSH	EDEM3	641	Q9BZQ6
NQHDVPVIPLDVVDN	CASP6	166	P55212
NHVDAQVQTEAPVPV	DYNC2I2	81	Q96EX3
SEEPLQVLEHPRQEQ	ERAP1	116	Q9NZ08
AQVIIHVRDVNDSPP	FAT2	1856	Q9NYQ8
IPQEDFQTLTPDVVH	L3MBTL1	696	Q9Y468
IHITLQVTDINDNPP	PCDHGA9	436	Q9Y5G4
EVAALQPPVVQLHDS	COL18A1	1501	P39060
IQPDHPQISQQVAAS	HERC4	471	Q5GLZ8
PQVATIHITPVDDQL	FREM1	626	Q5H8C1
IVSRHPDPQVSEQQL	IL16	436	Q14005
LQEAAPEVVQPTTVQ	DDX28	141	Q9NUL7
QQTPLHLAVITNQPE	NFKBIA	111	P25963
HVNIVNVPQPAAAAI	MYB	266	P10242
QVPHIVVKNQIISQP	MED17	321	Q9NVC6
LPVHNQVLPSIESVD	PRDM10	101	Q9NQV6
LHLQPQHEESVVPTQ	PRDM10	481	Q9NQV6
EGSPHDNPTVQQIVQ	GOLGA6B	671	A6NDN3
HVNNVVNAPLSINIP	PPP2R3A	696	Q06190
QTHIFQVNVPPVIRV	FSTL5	331	Q8N475
VQANLPPHIQTKTVV	METTL21A	106	Q8WXB1
ANQEVPPPVEQQLVH	CSGALNACT2	406	Q8N6G5
EVNPQADQLPHVERK	FCAMR	496	Q8WWV6
EHQPVLRCQIIEPNI	HYDIN	3131	Q4G0P3
QHETVIPGELPLVQE	DOCK5	76	Q9H7D0
NISKEAPPHNIQIFV	GCNT4	286	Q9P109
PEQVIPINSEELFVH	CELA3A	96	P09093
PVVERNNHQTELEVP	FRS2	116	Q8WU20
AVQQIEKIHPFTIPA	FASTKD1	561	Q53R41
TEPVVLTFQHQLQPK	ADGRG1	326	Q9Y653
PPEASVQIHQVAQVR	LTBP2	481	Q14767
KQVSEHPVQPTETQV	IL12RB1	491	P42701
DTHNIIVNQLVFPDP	GET3	271	O43681
VEPQPVLEDNVVTFH	KIRREL3	256	Q8IZU9
FELQQTEPVNPIVQH	FRY	1496	Q5TBA9
EQKEQVNPDHVPESI	CCDC168	3101	Q8NDH2
LTHQALVPPQDVVNK	BICRA	176	Q9NZM4
ANVETQIPPIHEQFA	DNAH2	1086	Q9P225
NVQSIADIHPIQVQP	PHKA2	461	P46019
AVHVESVLNRVPQPE	PHKA2	1121	P46019
EALHISGPQPQLQQV	POM121L1P	396	Q3SYA9
QDTQEVIVVPHSLPF	PDGFRB	516	P09619
PVPDPSVAQVLVEHN	PKD1	1076	P98161
VQVEEKLLPQPVIQH	KIF17	386	Q9P2E2
PNEVIVKVHAASVNP	RTN4IP1	71	Q8WWV3
PTEQVNELVALIPHS	TMEM106C	61	Q9BVX2
PTSQNNDIQPHSVVE	RNF133	356	Q8WVZ7
ATHPAVLQENTQIEP	RPGRIP1	476	Q96KN7
NIDIPTTQQVPHIEA	SMCHD1	1676	A6NHR9
EPVLETPVESQQHEI	STAT2	131	P52630
EPEHQEALQPVNLSE	SYNE2	4351	Q8WXH0
TAELNVQVPEEPTHL	MIA3	1071	Q5JRA6
IINVNVAVPSVHVPE	LRRC15	466	Q8TF66
VPHVQVKDVPNFEQL	PNPLA5	296	Q7Z6Z6
VVPHASENLVSQVPQ	SPATA31A7	1041	Q8IWB4
HPEVQSILKISQPQE	SGK1	51	O00141
PVVIQPSQHSVALLN	KIAA1217	891	Q5T5P2
QNPIVPETQVLHEEI	TENM2	1046	Q9NT68
QQPVTADKQQGHEPV	WAC	496	Q9BTA9
PHIPANQEVLNKVEV	ADSS2	386	P30520
LEISPQNVDVNVHPT	MLH1	296	P40692
ELIPQQRHESKPVNV	RBIS	76	Q8N0T1
VPHDQVDATLIPITN	SLC25A38	206	Q96DW6
PPHIIHVPAEQIQQQ	SATB1	581	Q01826
PIVINHVISVDPNDQ	SMARCD2	386	Q92925
HNQERPTAAVTPIQV	SH3RF1	596	Q7Z6J0
NPEAITEVVQLPNHF	STC1	141	P52823
SQIQQVPVLLQPHFI	SREBF1	231	P36956
TIHQDPQSIFVTNPV	ANKHD1	2151	Q8IWZ3
TVQPLLQEQEQHVPF	NCAPH2	501	Q6IBW4
PEEIISNEVHNLNPV	RNF17	886	Q9BXT8
VVPHASENLVSQVPQ	SPATA31A3	1041	Q5VYP0
PINFHQNDPVEIKAV	TM9SF4	31	Q92544
VVPHASENLVSQVPQ	SPATA31A1	1041	Q5TZJ5
VVPHASENLVSQVPQ	SPATA31A5	1041	Q5VU36
PVISQNIHAPIANES	TRO	176	Q12816
INTTLPPHEQVTAQE	TRABD2B	276	A6NFA1
SNIPVAKVVPQQITH	SAP130	426	Q9H0E3
NISLELVVNVPPQIH	FLT4	411	P35916
LVVNVPPQIHEKEAS	FLT4	416	P35916
QTHKENPVLDVVSNP	TP53BP1	51	Q12888
QVHKETIDAVPNAIP	ZNF207	56	O43670
PSPHTLQEVQVAIIN	PRSS21	186	Q9Y6M0
EFEVNIHVPAPELQS	HDLBP	1001	Q00341
PVANVPAVQQTLIHS	WNK1	1606	Q9H4A3
SHEGQRQPQIEPEQI	HIVEP2	41	P31629
AQKAPEAEAHPVQIQ	ZFYVE26	1116	Q68DK2
QPQNEEVHIIELITP	TGFBR3	226	Q03167
APEVTTVQLQPAQEV	ZNF628	826	Q5EBL2
DVHVPVPELNNVISL	LRP4	1376	O75096